Patents by Inventor John Corbin

John Corbin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mattress function indicator on graphical user interface for bed
    Patent number: 12075916
    Abstract: A patient support apparatus may include a mattress configured to receive a fluid from a pneumatic system, a graphical user interface, and a controller configured to control the pneumatic system and to communicate with the graphical user interface. The controller may control the graphical user interface to selectively display a home screen comprising a plurality of icons, the icons comprising a mattress function menu icon and a mattress function screen accessible via the mattress function menu icon. The mattress function screen may include at least one control input configured to activate a first state and a second state of the controller.
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: September 3, 2024
    Assignee: Hill-Rom Services, Inc.
    Inventors: David Newkirk, Brandon Fisk, Gregory Shannon, Scott Corbin, Rachel L. Williamson, John Goewert
  • Human immunodeficiency virus neutralizing antibodies
    Patent number: 11655285
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: May 23, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220372163
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: May 30, 2022
    Publication date: November 24, 2022
    Applicant: TRISHULA THERAPEUTICS, INC.
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220340680
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • NOVEL MODULATORS
    Publication number: 20220227857
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Anti-CD39 antibodies
    Patent number: 11345757
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 31, 2022
    Assignee: Trishula Therapeutics, Inc.
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20220135689
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 5, 2022
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • Modulators
    Patent number: 11261247
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 1, 2022
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210403593
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies
    Patent number: 11208487
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: December 28, 2021
    Assignee: Tizona Therapeutics
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20210340259
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: November 4, 2021
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20210155676
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: December 3, 2020
    Publication date: May 27, 2021
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210009708
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 14, 2021
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • Human immunodeficiency virus neutralizing antibodies
    Patent number: 10882898
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: January 5, 2021
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20200102390
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • Robust and error free physical unclonable function using twin-cell charge trap transistor memory
    Patent number: 10468104
    Abstract: The present disclosure relates to a structure which includes a pair of non-volatile storage devices in a memory array which are sensed to determine an initial data state and reinforced by a write operation of the initial data state to the pair of non-volatile storage devices. The structure can be used for a robust and error free physical unclonable function.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: November 5, 2019
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Darren L. Anand, William Roy John Corbin
  • HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20190211083
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: February 12, 2019
    Publication date: July 11, 2019
    Applicant: Gilead Sciences, Inc.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
    Patent number: 10253101
    Abstract: The present disclosure relates, in general, to methods of treating or preventing hypoglycemia using a negative modulator antibody fragment that binds to the insulin receptor and modulates the action of insulin at the insulin receptor.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: April 9, 2019
    Assignee: XOMA (US) LLC
    Inventors: Paul Rubin, Toshihiko Takeuchi, Hassan Issafras, Kiranjit Ahluwalia, John Corbin, Ira Goldfine, Kirk Johnson, Ou Li, Daniel Bedinger
  • Human immunodeficiency virus neutralizing antibodies
    Patent number: 10239935
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: March 26, 2019
    Assignee: Gilead Sciences, Inc.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20190062448
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: February 28, 2019
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield